Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
暂无分享,去创建一个
Steven Piantadosi | Misop Han | Alan W Partin | Marianna Zahurak | A. Partin | P. Walsh | S. Piantadosi | Misop Han | M. Zahurak | Patrick C Walsh | Johnathan I Epstein | J. I. Epstein
[1] P. Walsh,et al. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. , 1979, The Journal of urology.
[2] W. Catalona,et al. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. , 1998, The Journal of urology.
[3] A W Partin,et al. Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.
[4] W. Catalona,et al. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. , 1994, The Journal of urology.
[5] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[6] A W Partin,et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.
[7] D. Cox. Regression Models and Life-Tables , 1972 .
[8] F. Marshall,et al. Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. , 1995, Urology.
[9] Thomas M. Wheeler,et al. A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer , 1998 .
[10] J. Epstein,et al. Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy. , 1999, Urology.
[11] E. Bergstralh,et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. , 2000, The Journal of urology.
[12] A. Partin,et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.
[13] A W Partin,et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. , 2001, The Journal of urology.
[14] P. Scardino,et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? , 1994, The Journal of urology.
[15] J. Oesterling,et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.
[16] E. Bergstralh,et al. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. , 2001, Urology.
[17] R. B. Smith,et al. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. , 1994, The Journal of urology.
[18] A W Partin,et al. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.
[19] M. Kattan,et al. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] A. Partin,et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. , 1997, The Urologic clinics of North America.